Featuring perspectives from Dr Natalie S Callander and Dr Paul G Richardson, including the following topics:

• Introduction: Clinical Trials We LOVE to Discuss (0:00)
• Mechanism of Action of Cereblon E3 Ligase Modulators (CELMoDs) (8:42)
• Available Efficacy Data with CELMoDs in the Management of Relapsed/Refractory Multiple Myeloma (MM) (15:59)
• Extramedullary Disease (19:23)
• Spectrum and Management of CELMoD-Associated Adverse Events (30:12)
• Ongoing Phase II and III Trials Evaluating CELMoDs for MM (34:53)

CME information and select publications

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics:

• Case: A man in his early 60s with urothelial bladder cancer (UBC) is found to have metastatic disease shortly after surgery (0:00)
• Case: A man in his late 70s experiences disease progression after first- and second-line treatment for metastatic disease (7:39)
• Case: A fit man in his early 70s presents with metastatic disease (15:22)

CME information and select publications

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics:

• Introduction (0:00)
• Up-Front Treatment of Ovarian Cancer (OC) (1:13)
• Management of Platinum-Resistant OC (11:49)
• Up-Front Management of Metastatic Endometrial Cancer (32:42)
• Management of HER2-Positive Gynecologic Cancers (45:11)
• Management of Cervical Cancer (53:10)

CME information and select publications